George Freeman corrected a written answer on Osteoporosis
Liz Kendall (Labour, Leicester West) asked written question 211732 on 23 October 2014. George Freeman answered on 29 October 2014 for the Department of Health, and George Freeman corrected the answer on 13 November 2014. The same corrected answer was given to questions 211734, 211730, 211735, 211885, 211918. The correction replaced 10 figures (17.2, 17.5, 18.8, 19.4, 19.9, 21.0) with 10 figures (10.0, 3.6, 4.5, 5.3, 5.4, 6.6). Altogether 20 words differ between the two versions.
The question
To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.
Original and corrected answer
Struck through: original only. Bold: correction only.
| Original | Corrected |
|---|---|
| The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships. £ million | 2009-10 | 2010-11 | 2011-12 | 2012-13 | 2013-14 Asthma Medical Research Council | | | | | Other Research Councils and Innovate UK | 0.0 | 0.1 | 0.3 | 1.5 | 0.8 National Institute for Health Research | 2.6 | 3.4 | 2.4 | 3.4 | 3.8 Total | | | | | Motor Neurone Research Medical Research Council | 7.0 | 7.5 | 4.2 | 4.1 | 3.6 Other Research Councils and Innovate UK | 0.2 | 0.2 | 0.4 | 0.7 | 1.0 National Institute for Health Research | 0.1 | 0.1 | 0.4 | 0.7 | 0.5 Total | 7.3 | 7.8 | 5.0 | 5.5 | 5.1 Osteoporosis Medical Research Council | 6.2 | 5.4 | 5.1 | 4.6 | 5.9 Other Research Councils and Innovate UK | 0.0 | 0.0 | 0.1 | 0.4 | 1.0 National Institute for Health Research | 0.3 | 0.7 | 0.8 | 1.3 | 1.8 Total | 6.5 | 6.1 | 6.0 | 6.3 | 8.7 The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma. Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure. Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available. | The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships. £ million | 2009-10 | 2010-11 | 2011-12 | 2012-13 | 2013-14 Asthma Medical Research Council | 6.6 | 5.3 | 4.5 | 3.6 | 5.4 Other Research Councils and Innovate UK | 0.0 | 0.1 | 0.3 | 1.5 | 0.8 National Institute for Health Research | 2.6 | 3.4 | 2.4 | 3.4 | 3.8 Total | 9.2 | 8.8 | 7.2 | 8.5 | 10.0 Motor Neurone Research Medical Research Council | 7.0 | 7.5 | 4.2 | 4.1 | 3.6 Other Research Councils and Innovate UK | 0.2 | 0.2 | 0.4 | 0.7 | 1.0 National Institute for Health Research | 0.1 | 0.1 | 0.4 | 0.7 | 0.5 Total | 7.3 | 7.8 | 5.0 | 5.5 | 5.1 Osteoporosis Medical Research Council | 6.2 | 5.4 | 5.1 | 4.6 | 5.9 Other Research Councils and Innovate UK | 0.0 | 0.0 | 0.1 | 0.4 | 1.0 National Institute for Health Research | 0.3 | 0.7 | 0.8 | 1.3 | 1.8 Total | 6.5 | 6.1 | 6.0 | 6.3 | 8.7 The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma. Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure. Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available. |
The question and answer on the Parliament website.
More on George Freeman.
Receipt
| Read from | https://questions-statements-api.parliament.uk/api/writtenquestions/questions/100721?expandMember=true |
|---|---|
| Date read | 15 October 2026 |
| SHA-256 | c72625aba1593fda3c8e4538c0a6137fb9a3d8665880a2a528b40801f55c10ef |